The rapid spread of human immunodeficiency virus type 1 (HIV-1) in humans has been accompanied by continuous extensive genetic diversification of the virus. The aim of this study was to investigate the impact of HIV-1 diversification on HIV-1 replication capacity (RC) and mutational robustness. Thirty-three HIV-1 protease sequences were amplified from three groups of viruses: two naïve sample groups isolated 15 years apart plus a third group of protease inhibitor-(PI) resistant samples. The amplified proteases were recombined with an HXB2 infectious clone and RC was determined in MT-4 cells. RC was also measured in these three groups after random mutagenesis in vitro using error-prone PCR. No significant RC differences were observed between recombinant viruses from either early or recent naïve isolates (P50.5729), even though the proteases from the recent isolates had significantly lower sequence conservation scores compared with a subtype B ancestral sequence (P,0.0001). Randomly mutated recombinant viruses from the three groups exhibited significantly lower RC values than the corresponding wild-type viruses (P,0.0001). There was no significant difference regarding viral infectivity reduction between viruses carrying randomly mutated naïve proteases from early or recent sample isolates (P50.8035). Interestingly, a significantly greater loss of RC was observed in the PI-resistant protease group (P50.0400). These results demonstrate that protease sequence diversification has not affected HIV-1 RC or protease robustness and indicate that proteases carrying PI resistance substitutions are less robust than naïve proteases.
INTRODUCTION
Like other RNA viruses, human immunodeficiency virus type 1 (HIV-1) is highly mutable, highly adaptable and is capable of rapid evolution (Más et al., 2010) . Since the introduction of the most recent common ancestor of the HIV-1 group M in humans (Sharp & Hahn, 2011) , the viral population has become extraordinarily diverse (Hemelaar, 2012; Korber et al., 2000) . The rate of evolution has been estimated to be 0.0024 substitutions per base pair per year for the HIV-1 gp160 envelope protein and 0.0019 for the HIV-1 gag protein (Korber et al., 2000) (reviewed in Vermund & Leigh-Brown, 2012) . As a consequence, sitespecific sequence conservation values have decreased over time at the population level. This raises the question: to what extent is viral diversification influencing HIV-1 fitness and virulence over the course of the epidemic?
HIV-1 transmission is characterized by an acute genetic bottleneck in which a single transmitted founder virus frequently establishes infection (Derdeyn et al., 2004; Keele et al., 2008) . Drastic ex vivo replication capacity (RC) losses are observed in HIV-1 upon serial plaque-to-plaque bottleneck events in MT-4 cells (Yuste et al., 1999) . Analysis of the entire genomic nucleotide sequences of formerly bottlenecked viruses showed the accumulation of 4-28 mutations per genome (Yuste et al., 2000) . These results confirmed the effect of Muller's ratchet, which describes the tendency of populations of asexual organisms to lose fitness due to the accumulation of deleterious mutations that cannot be compensated for by sex or recombination (Muller, 1964) . Another key issue is the potential impact of immune-mediated or drug-resistant mutations on HIV-1 RC at the population level (Chopera et al., 2011) . Cytotoxic T lymphocyte (CTL) and antiretroviral drug escape mutations are detrimental to HIV-1 RC (Leslie et al., 2004; Martinez-Picado et al., 1999; Nijhuis et al., 1999 ), yet they may persist in new hosts in the absence of immune or drug pressure. Most of the RCreducing escape mutations occur in conserved viral regions (Troyer et al., 2009) . RC defects can, at least in part, be restored by secondary compensatory mutations. Transmission of low RC HIV-1 escape variants may provide a clinical benefit to recipients (Stoddart et al., 2001 ); however, this benefit can diminish over time due to the reversion of the escape mutations (Leslie et al., 2004) or to the emergence of compensatory substitutions (MartinezPicado et al., 1999; Nijhuis et al., 1999) . Large cohort studies have also shown that HIV-1 is adapting to human leukocyte antigen (HLA) and CTL host responses (Kawashima et al., 2009) . Since the HIV-1 set-point viral load, which is strongly associated with disease progression, is largely determined by virus genotype (Alizon et al., 2010) , knowing how HIV-1 host adaptation is imprinting recently transmitted viral genomes and how these viral genomic changes are shaping viral RC has clinical relevance.
The purpose of this study was to investigate the impact of HIV-1 diversification on ex vivo HIV-1 RC. We investigated the impact of the accumulation of amino acid substitutions over time within the viral protease. Data about the impact of HIV-1 diversification on individual viral proteins are lacking. We investigated protease diversification in early and recent naïve samples isolated 15 years apart. Proteases carrying PI resistance mutations were also analysed. Although the protease is probably not the major gene that governs viral RC, we decided to study the HIV-1 protease because numerous studies have described its variability and the polymorphisms found in naïve or PI-treated infected individuals, which suggest the high evolvability of this protein. Moreover, we and others have used site-directed and random mutagenesis to show that the HIV-1 protease can undergo many amino acid changes without losing its enzymic activity (Loeb et al., 1989; Parera et al., 2007) . As an alternative to possible adaptation to its host, it has been proposed that HIV-1 may be shifting towards the possession of increasingly robust population characteristics (Rolland et al., 2007) . Recently, it has been demonstrated that mutational robustness can facilitate adaptation, suggesting that robustness can be a selectable trait (Draghi et al., 2010) . Therefore, we also investigated the effects of HIV-1 protease diversification on protease robustness.
RESULTS
Decreases in HIV-1 protease sequence conservation over time HIV-1 diversification over time was explored by randomly selecting 139 protease sequences from two sets of samples isolated 15 years apart. The 'early' proteases (n589) were obtained from samples isolated in 1993 and 1994 from naïve chronically infected patients with an unknown date of infection (mean viral load±SEM5123 183±23 813 copies ml
21
, mean CD4
+ cell count±SEM5352±26 cells 1993 -1994 , to 0.041±0.002 during 2006-2007 (P,0.0001, unpaired t-test) (Fig. 1a) . Amino acid sequence diversification also significantly increased from 0.037±0.002 during 1993-1994 to 0.053±0.003 during 2006-2007 (P,0.0001) (Fig. 1b) . Similar results were obtained when sequences were compared to the subtype consensus sequence (data not shown). Genetic distances not only increased significantly compared with an ancestral or consensus sequence but also increased as determined by intra-group p-distance diversity. There was an increase from 0.032±0.004 to 0.062± 0.006, respectively, for nucleotide distances (P,0.0001), and from 0.049±0.012 to 0.077±0.016, respectively, for amino acid distances (P,0.0001). The amino acid entropy was significantly higher (P¡0.05) in the recent proteases at residues 36, 41, 60, 61, 63, 65, 67 and 72 . A higher synonymous-to-non-synonymous (d S /d N ) ratio was found in more recent sequences (5.0±0.4 and 4.4±0.4, respectively); however, this did not reach statistical significance (P50.2886). The high d S /d N ratios implies that the protease gene was mainly under purifying selection. Positive selection pressures were also evaluated using the fixed effects likelihood (FEL) method, which was used to directly estimate synonymous and non-synonymous substitution rates at each site (Kosakovsky Pond & Frost, 2005) . We identified a total of seven positively selected codons which are frequent polymorphisms in HIV-1 subtype B proteases: three positively selected codons (T12, E35 and L63) were identified in the early samples and four codons (L33, N37, V77 and I93) were identified in the recent samples.
Full-length gag sequences from early (n540) samples also had significantly lower nucleotide diversification values than those from recent samples (n541) (0.033±0.001 during 1993-1994 versus 0.050±0.001 during 2006-2007, P,0.0001, unpaired t-test) . Similarly, amino acid sequence diversification significantly increased from 0.045±0.001 during 1993-1994 to 0.061±0.002 during 2006-2007 (P,0.0001) . As expected, protease diversification was highly correlated with gag nucleotide diversification (r50.320, P,0.0001, linear regression) and amino acid diversification (r50.1786, P,0.0001, linear regression). Protease diversification was also highly correlated with diversification of other viral genes (data not shown).
Relationship between HIV-1 protease sequence conservation and viral RC To investigate whether HIV-1 protease sequence diversification affected viral RC, 22 proteases were non-randomly selected from the set of 139 proteases. These 22 proteases were selected on the basis of their high or low divergence from the ancestral subtype B protease amino acid sequence ( Fig. 2a and b ). Bulk patient plasma-derived PCR protease amplicons were recombined with a protease-deleted HXB2 infectious clone. Consequently, a patient protease quasispecies of sequences was recombined. In addition, 11 proteases carrying PI resistance mutations (mean viral load±SEM540 364± 12 201 copies ml
+ cell count±SEM5149±41 cells ml
) that were isolated in 2009-2011 were also PCR amplified, recombined with the HXB2 infectious clone and included in the analysis (Fig. 2c) . The protease region of the chimeric viruses was then sequenced from the resultant chimeric viral stocks and compared to the original source plasma (Fig. 3) . A mean±SD of 0.30±0.34 % and 0.34±0.79 % difference at the nucleotide and amino acid level, respectively, was observed between plasma HIV RNA and chimeric virus. These data indicated that although there may have been some selection of chimeric viruses during recombination and/or culture, protease chimeric viruses represented the dominant form of plasma viruses and selection during culture was unlikely to affect the overall analysis. To quantitatively compare the ex vivo RC of the resulting 33 chimeric viruses, MT-4 cells were co-transfected and viral growth was measured by quantifying the viral p24 antigen on days 0-7 after transfection (Fig. 4a) . The RC of the bulk (quasispecies-containing) recombinant viruses was assayed in three independent experiments, and the mean RC values were calculated. No correlation was found between the starting sample quasispecies diversity and ex vivo viral RC (data not shown). Chimeric viruses derived from naïve samples isolated during 1993-1994 showed ex vivo viral RC that was similar to the RC of viruses from naïve samples isolated during [2006] [2007] (Fig. 4b) . The mean±SEM RC of the early (1993) (1994) viruses was 98±4 %, and that of the recent (2006) (2007) viruses was 96±2 % (P50.5729). Viral RC was also compared by determining how conserved the proteases sequences were relative to an ancestral subtype B sequence. There was no positive relationship between conservation of sequences and their relative RC ex vivo (r50.0322, P50.4241, linear regression), nor was there a positive correlation between viral RC and plasma viral load in naïve patients (r50.0238, P50. 3916, linear regression). Remarkably, some early (1993) (1994) viruses were genetically related much more to ancestral B sequence (Fig. 3) , suggesting that older ancestral viruses may have an RC similar to recent viruses. As expected, chimeric viruses carrying PI resistance mutations showed significantly lower RC ( Fig. 4a and b) . The mean RC of the PI-resistant proteases was 83±3 % (P50.0044 and P50.0021, for early and recent proteases, respectively). As for naïve patients, there was no positive relationship between sequence conservation and relative ex vivo RC (r50.0019, P50.8978, linear regression). Taken together, these results demonstrate that HIV-1 protease diversification over time has not influenced ex vivo viral RC.
Relationship between HIV-1 protease robustness and viral RC
The mutational robustness of the 33 proteases analysed in this study was also investigated. To compare the robustness of these proteases, we used PCR mutagenesis to generate randomly mutated libraries of the different proteases. To quantify the mutant frequency generated by PCR mutagenesis, 132 individual protease clones from 6 of 33 patient protease libraries were sequenced (Table 1) . The mutagenic PCR used in this study had a mean mutation frequency per nucleotide of 1.72610 22 ±0.23 (Table 1 ). The 33 PCR mutated libraries were recombined with a protease-deleted HXB2 infectious clone. Similar to the amplified proteases in patient samples, chimeric viruses carrying mutated protease libraries were grown in MT-4 cells and their RC values were compared to those of the corresponding wildtype recombinant viruses ( Fig. 5a and b) . All PCR mutated proteases displayed a significant reduction in virus-specific infectivity. Mutated proteases from each of the three groups of proteases of this study showed a significant HIV-1 protease evolution, fitness and robustness reduction in viral growth (P,0.0001, P,0.0001 and P,0. were compared with randomly mutated proteases from naïve samples, a significant mean reduction in viral infectivity was observed (P,0.0001 and P,0.0001, for early and recent samples, respectively). Importantly, the mean±SEM reduction of viral infectivity of randomly mutated naïve proteases was 18±1 %, and the mean reduction of viral infectivity of randomly mutated proteases carrying PI resistance mutations was 25±3 % (P5 0.0400), indicating that proteases carrying PI resistance substitutions were less robust than naïve proteases. (Rolland et al., 2007) . Others have found that recent isolates have higher ex vivo RC than earlier isolates, suggesting that HIV-1 virulence may be increasing (Gali et al., 2007) . However, these studies have not focused on the impact of HIV-1 diversification on HIV-1 RC and mutational robustness or specifically on the impact of HIV-1 diversification on the fitness of individual viral proteins. In this study, we tested whether HIV-1 diversification over time had affected ex vivo HIV-1 RC and protease robustness.
We found no significant ex vivo RC differences between viruses carrying naïve proteases from early or recent sample isolates, even though recent proteases have significantly diverged compared with a subtype B ancestral or consensus sequence. This finding is in good agreement with in vivo studies that have not found HIV-1 attenuation over time (Dorrucci et al., 2005 (Dorrucci et al., , 2007 Herbeck et al., 2008; Müller et al., 2006; Sinicco et al., 1997; Troude et al., 2009; van Manen et al., 2011; Vanhems et al., 1999) . No changes in RC or even in disease progression were detected in these in vivo studies. Recently, a meta-analysis of trends in HIV-1 plasma viral load and CD4 + T-cell count, two prognostic markers of HIV disease progression, suggested that HIV-1 has become more virulent over the .30 year history of the global HIV-1 epidemic (Herbeck et al., 2012) . Mathematical modelling has demonstrated that an increase in the parasite dispersal rate leads to selection for increased growth and to higher virulence (Wild et al., 2009) . Although we investigated the RC of HIV-1 carrying protease resistance mutations in the background of wild-type R M 1 9 9 3 -1 9 9 4 2 0 0 6 -2 0 0 7 R M 2 0 0 6 -2 0 0 7 P I r e s i s t a n t R M P I r e s i s t a n t Fig. 4(b) . The values represent the means of at least three independent experiments. P-values were determined using the unpaired t-test.
gag protein, our results confirm previous reports in which viruses carrying protease resistance mutations had significantly lower ex vivo RC than naïve viruses (Martinez-Picado et al., 1999; Nijhuis et al., 1999) . We also investigated whether the mutational robustness of naïve viral proteases was being affected by the progressive accumulation of new amino acid substitutions over time. Our results demonstrated that diversification of HIV-1 naive proteases has not affected their robustness. Although robustness seems to be the opposite of evolvability, it has been shown recently that neutral diversity in a robust population, such as that observed in the recent proteases, can accelerate adaptation (Draghi et al., 2010) . Several studies have documented the relevance of neutral variation in allowing a population to access adaptive phenotypes (van Nimwegen, 2006) . Our study also showed that PI-resistant proteases are significantly less robust than naïve proteases. This finding, together with the RC cost of resistance mutations, explains why some resistance mutations revert to wild-type residues in the absence of the specific drug (Martinez-Picado & Martínez, 2008) .
Remarkably, to our knowledge this is the first study to investigate the impact of accumulation of amino acid substitutions over time in an individual viral protein (protease) on HIV-1 RC and mutational robustness. Our results provide convincing evidence that over time, HIV-1 protease diversification has not affected HIV-1 RC or protease mutational robustness and suggest that proteases carrying PI resistance substitutions are less robust than naïve proteases.
This study has some limitations. First, although our hypotheses were supported statistically, our study was restricted to a relatively epidemiologically homogeneous cohort of HIV-1-infected patients who sought care at our clinic. Second, analysis of other viral proteins or viral genomic regions may broaden our study conclusions. Third, RC differences can be substantial enough to have important evolutionary consequences, but nevertheless be too small to detect them experimentally. Further work should include an analysis of other viral genes to evaluate whether HIV-1 diversification over time is preferentially affecting other viral genomic regions. CTL escape mutations are gradually being imprinted in HIV-1 sequences as the epidemic progresses. In the case of gag and pol (as well as accessory genes) d S /d N ratios are high and positive selection can be discerned at sites corresponding to T-cell epitopes. It has been shown that virtually all of the amino acid diversity accumulating in these genes in untreated infection can be attributed to escape from the CTL response (Kearney et al., 2009; Walker & McMichael, 2012) , suggesting that CTL escape mutations may be driving the diversification of HIV-1 protease. Nevertheless, it cannot be discarded that the introduction of protease inhibitors or transmission bottlenecks may be affecting the diversification of recent (2006) (2007) HIV-1 proteases. CTL escape mutations may differentially impact viral RC depending on the viral coding-region in which they emerge. For instance, CTL escape mutations in HIV-1 gag p24 are associated with significant RC costs, whereas most escape mutations in the env gene are neutral (Troyer et al., 2009) . A better understanding of how ongoing HIV-1 diversification affects viral RC and robustness has clinical implications for the design of effective therapeutic and vaccine strategies against circulating viruses.
METHODS
Patients. This study analysed 150 samples from 150 HIV-1-infected patients at our HIV clinic. All patients were infected with HIV-1 subtype B. In addition, 139 samples were obtained from naïve patients chosen at random, and 11 samples were collected from PItreated patients who were failing therapy. Ex vivo viral RC determinations and mutational robustness experiments were performed on 33 samples.
Recovery and analysis of HIV-1 protease and gag sequences.
RNA extraction and amplification were performed as described previously (Fernàndez et al., 2007; Ibáñez et al., 2000; Parera et al., 2004) . Briefly, HIV-1 RNA was extracted from 140 ml of plasma and amplified by PCR using a nested primer set. After the viral RNA was isolated, 5 ml of resuspended RNA was reverse transcribed and PCR amplified using the SuperScript III One-Step RT-PCR System with Platinum Taq DNA polymerase (Invitrogen) and 10 pmol of oligonucleotides: 59 prot 1 (sense) (59-AGGCTAATTTTTTAGGG-AAGATCTGGCCTTCC-39, HXB2 residues 2078-2109) and 39 prot 1 (antisense) (59-GCAAATACTGGAGTATTGTATGGATTTTCAGG-39, HXB2 residues 2703-2734). A second amplification (nested PCR) was carried out with oligonucleotides 59 prot 2 (sense) (59-TCAGAGCAGACCAGAGCCAACAGCCCCA-39, HXB2 residues 2136-2163) and 39 prot 2 (antisense) (59-AATGCTTTTATTTTT-TCTTCTGTCAATGGCC-39, HXB2 residues 2620-2650). The amplified proteases were sequenced with the flanking oligonucleotides 59 prot 2 and 39 prot 2 using the Big Dye v3.1 kit and the 3100 DNA sequencing system (Applied Biosystems). The HIV-1 gag coding region was PCR amplified with oligonucleotides as described previously (Miura et al., 2009) . Briefly, 5 ml of extracted RNA were used for the reaction, which was performed using the SuperScript III One-Step RT-PCR System with Platinum Taq DNA polymerase (Invitrogen) and 10 pmol of oligonucleotides: 59gag1 (sense) (59-AAATCTCTAGCAGTGGCGCCCGAACAG-39, HXB2 residues 623-649) and 39gag1 (antisense) (59-TAACCCTGCGGGATGTGGT-ATTCC-39, HXB2 residues 2826-2849). A second amplification (nested PCR) was carried out with 59gag2 (sense) (59-GACT-CGGCTTGCTGAAGCGCGCACGGCAAGAGGCGAGGGGCGGC-GACTGGTGAGTACGCCAAAAATTTTGACTAGCGGAGGCTAG-AAGGAGAGAGATGGG-39, HXB2 residues 695-794) and 39gag2 (antisense) (59-GGCCCAATTTTTGAAATTTTTCCTTCCTTTTC-CATTTCTGTACAAATTTCTACTAATGCTTTTATTTTTTCTTCT-GTCAATGGCCATTGTTTAACTTTTG-39, HXB2 residues 2605-2704). Gag sequencing was performed with the Big Dye v3.1 kit and the 3100 DNA sequencing system (Applied Biosystems) using oligonucleotides s59gag2 (59-GGGCGGCGACTGGTGAGT-39, HXB2 residues 732-749), s39gag2 (59-CTTTATTGTGACGAGG-GGTCG-39, HXB2 residues 2274-2294), 5protRv (59-AGGGGTC-GTTGCCAAAGAGTG-39, HXB2 residues 2281-2261) and 1Bwt (59-AGGTGGATTATTTGTCATCCATCCTATTTGTTCCTGAA-GG-39, HXB2 residues 1515-1554). Sequence alignment and editing was performed with the Sequencer software program, version 4.1 (GeneCodes). Nucleotide and amino acid p-distances were calculated using the MEGA 5 software package (Tamura et al., 2007 Generation of chimeric viruses. Recombinant viruses were generated as described previously (Betancor et al., 2010; Kisic et al., 2011) . Briefly, bulk full-length protease PCR products obtained from patient plasma were purified with the QIAquick PCR Purification kit (Qiagen). PCRs were performed with oligonucleotides 59 prot 1, 39 prot 1, 59 prot 2 and 39 prot 2 (see above). The resulting PCR fragment was 514 bp long and had 90 bp overlap at the 59 end and 98 bp overlap at the 39 end with the protease-deleted HXB2 plasmid. One-hundred and fifty nanograms of the PCR products was cotransfected into MT-4 cells with 1 mg of protease-deleted HXB2 clone that had been previously linearized with BstEII (Maschera et al., 1995) . Cell culture supernatants were harvested on days 3, 5 and 7 after transfection. Under these culture conditions, a robust and clear exponential curve could be plotted before it plateaued 6-7 days posttransfection. RC assays were performed in triplicate. The slope of the natural log of per cent of p24 antigen production was calculated between days 0 and 7. To discard that the exponential increase of p24 in the supernatant was simply the accumulation of p24 from the transfected MT-4 cells without new infection, infectivity titres were also determined (data not shown). The natural log was used for the slope calculation, which is appropriate for an exponential growth curve. The RC of each variant was compared with that of the virus with the HXB2 recombinant protease (100 %). On day 7 after transfection, viral RNA was extracted, reverse transcribed (as described above), and sequenced with the flanking oligonucleotides 59 prot 2 and 39 prot 2 using the Big Dye v3.1 kit and the 3100 DNA sequencing system (Applied Biosystems).
Construction of random HIV-1 protease mutation libraries. An error-prone PCR mutagenesis protocol was performed. PCR was carried out in 10 mM Tris/HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl 2 , 0.5 mM MnCl 2 , 0.2 mM of each oligonucleotide, 2.5 U Taq polymerase (Promega) and biased deoxynucleoside triphosphate concentrations (240 mM deoxycytidine triphosphate/1 mM deoxythymidine triphosphate/240 mM deoxyATP/1 mM deoxyguanosine triphosphate; Promega), as described previously (Parera et al., 2007) . The cycling parameters were as follows: 506(95 uC, 30 s; 50 uC, 30 s; 72 uC, 10 min). Input DNA was 1 ng of the corresponding HIV-1 protease PCR DNA per 100 ml reaction. The following PCR oligonucleotides were used: 59 prot 2 and 39 prot 2. The resulting PCR products were purified with the QIAquick PCR Purification kit (Qiagen) and recombined with 1 mg of proteasedeleted HXB2 clone that had been linearized with BstEII as described above. To compute the mutant frequencies generated by the mutagenic PCR, PCR products were cloned into the pGEM-T Easy vector (Promega), transformed by using One Shot Omni-MAX 2 T1 (Invitrogen) and subsequently sequenced using the ABI Prism Dye Terminator Cycle Sequencing kit (Applied Biosystems), as described previously . The composition of the library was determined by nucleotide sequencing of the encoded HIV-1 protease gene in individual plasmid colonies.
Statistical analysis. The unpaired t-test and linear regression analysis of covariates were performed using GraphPad Prism version 4.00 for Windows (San Diego, CA, USA).
